MedTrace Logo

A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity

NCT04415346 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2020-06-04

No results posted yet for this study

Summary

* Investigational Product: LIZTOX inj 100unit(HU-014)
* Title : A Single Center, Phase I Clinical Trial to Evaluate the Safety of LIZTOX Inj in the Treatment of Post Stroke Upper Limb Spasticity
* Sites and investigators : Asan Medical Center(Seoul), Min-ho Chun, M.D, Ph.D
* Objective : To evaluate the safety of LIZTOX inj in the treatment of Post Stroke Upper Limb Spasticity

Conditions

  • Post Stroke Upper Limb Spasticity

Interventions

BIOLOGICAL

HU-014 Inj

Clostridium botulinum type A

Sponsors & Collaborators

  • Huons Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Min-ho Chun, M.D.,Ph.D. · Department of Physical Medicine&Rehabilitation

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-06
Primary Completion
2020-06-30
Completion
2020-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04415346 on ClinicalTrials.gov